Prostate cancer
CAMO959A12103
A Phase Ib/II, open-label, multi-center study of the DDRi AMO959 with [177Lu]Lu-PSMA-617 in adults with PSMA positive metastatic castration resistant prostate cancer.
Trial overview
Clinical Area
Theranostics
Disease
Prostate
Disease site
Genitourinary (GU)
Study Phase
Phase I
Trial Identifiers
Registration number: NCT07226986
GenesisCare Location(s)
Principal Investigator(s)
Clinical trials enquiries